Literature DB >> 6213192

Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.

M H Cynamon, P A Granato.   

Abstract

The in vitro activity of teichomycin A2 was compared with that of vancomycin by standardized agar dilution testing against clinical isolates of staphylococci and enterococci. Both antibiotics had similar activities against staphylococci. However, teichomycin A2 was significantly more active against enterococci.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6213192      PMCID： PMC181923          DOI： 10.1128/AAC.21.3.504

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  2 in total

1.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

Authors:  F Parenti; G Beretta; M Berti; V Arioli
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

2.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.

Authors:  M R Bardone; M Paternoster; C Coronelli
Journal:  J Antibiot (Tokyo)       Date:  1978-03       Impact factor: 2.649
  2 in total
  31 in total

1.  Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection.

Authors:  W E Peetermans; J J Hoogeterp; A M Hazekamp-van Dokkum; P van den Broek; H Mattie
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

2.  In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.

Authors:  S Dixson; W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

3.  Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.

Authors:  G L Traina; M G Gentile; G Fellin; R Rosina; L Cavenaghi; G Buniva; M Bonati
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Binding of teicoplanin to human serum albumin.

Authors:  A Assandri; A Bernareggi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.

Authors:  H Y Chen; J D Williams
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

6.  In vitro activity of teicoplanin and vancomycin against anaerobes.

Authors:  Y Glupczynski; M Labbe; F Crokaert; E Yourassowsky
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

7.  Pharmacokinetics of teicoplanin in man after intravenous administration.

Authors:  G L Traina; M Bonati
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

8.  In vitro activity and human pharmacokinetics of teicoplanin.

Authors:  L Verbist; B Tjandramaga; B Hendrickx; A Van Hecken; P Van Melle; R Verbesselt; J Verhaegen; P J De Schepper
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

9.  Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.

Authors:  C U Tuazon; H Miller
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

10.  Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12, and 30 milligrams per kilogram of body weight to healthy male volunteers.

Authors:  J A Smithers; H K Kulmala; G A Thompson; K K Antony; E W Lewis; S J Ruberg; M T Kenny; J K Dulworth; M A Brackman
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.